Gratus Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $14.5M | Buy |
418,346
+10,173
| +2% | +$352K | 0.58% | 53 |
|
|
2024
Q1 | $11.8M | Buy |
408,173
+10,602
| +3% | +$307K | 0.54% | 60 |
|
|
2023
Q4 | $9.12M | Buy |
397,571
+104,702
| +36% | +$2.4M | 0.51% | 64 |
|
|
2023
Q3 | $4.89M | Buy |
292,869
+73,283
| +33% | +$1.22M | 0.33% | 77 |
|
|
2023
Q2 | $6.06M | Buy |
219,586
+7,855
| +4% | +$217K | 0.41% | 70 |
|
|
2023
Q1 | $4.87M | Sell |
211,731
-7,328
| -3% | -$169K | 0.37% | 67 |
|
|
2022
Q4 | $2.39M | Buy |
219,059
+12,946
| +6% | +$141K | 0.2% | 81 |
|
|
2022
Q3 | $1.74M | Buy |
+206,113
| New | +$1.74M | 0.18% | 89 |
|